Avidity Biosciences, Inc. (NASDAQ: RNA) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT AVIDITY BIOSCIENCES, INC.

Avidity Biosciences, Inc. (NASDAQ: RNA)
Listen to this Section


$12.24
+0.4750 ( +4.04% ) 109.7K

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

Market Data


Open $12.24
Previous Close $11.76
Volume 109.7K
Market Cap $201.16M
Day Range $11.69 - $12.24
52 Week Range $11.40 - $73.06
Shares Outstanding 17.11M
Change % +4.04%
Net Change ▲ 0.4750
Insider Ownership N/A
Exchange NASDAQ
SectorBasic Materials
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2026
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 112 Nov 10, 2025
8-k 8K-related 14 Nov 10, 2025
8-k 8K-related 16 Oct 27, 2025
4 Insider transactions 1 Oct 24, 2025
4 Insider transactions 1 Oct 17, 2025
8-k 8K-related 13 Oct 14, 2025
4 Insider transactions 1 Oct 07, 2025
4 Insider transactions 1 Sep 23, 2025
4 Insider transactions 1 Sep 17, 2025
4 Insider transactions 1 Sep 17, 2025

Latest News